Rafferty Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
A detailed history of Rafferty Asset Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 554,141 shares of IOVA stock, worth $2.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
554,141
Previous 652,966
15.13%
Holding current value
$2.12 Million
Previous $6.13 Million
33.13%
% of portfolio
0.01%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$105 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$93.3 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$84.5 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$81.1 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$46.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $603M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...